Kyung-Eun Lee Selected Research

Kyung-Eun Lee Research Topics

Disease

6	Neoplasms (Cancer) 04/2022 - 09/2010
4	Systemic Lupus Erythematosus (Libman-Sacks Disease) 05/2019 - 05/2017
4	Ischemic Stroke 01/2018 - 12/2009
3	Mouth Neoplasms (Oral Cancer) 12/2017 - 03/2013
3	Rheumatoid Arthritis 12/2017 - 09/2014
2	Chronic Renal Insufficiency 05/2019 - 02/2015
2	Lupus Nephritis 01/2019 - 02/2018
2	Inflammation (Inflammations) 01/2019 - 03/2013
2	Sclerosis 04/2018 - 02/2018
2	Cicatrix (Scar) 02/2015 - 05/2012
2	Ankylosing Spondylitis 01/2015 - 09/2014
2	Ankylosis 01/2015 - 09/2014
2	Wounds and Injuries (Trauma) 05/2013 - 05/2012
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2004 - 11/2003
1	Urinary Bladder Neoplasms (Bladder Cancer) 11/2022
1	Neutropenia 04/2022
1	Dihydropyrimidine Dehydrogenase Deficiency 02/2022
1	Ductal Carcinoma 01/2022
1	Hypertension (High Blood Pressure) 10/2021
1	Head and Neck Neoplasms (Head and Neck Cancer) 09/2021
1	Deglutition Disorders (Dysphagia) 10/2019
1	Hypoxia (Hypoxemia) 01/2019
1	Squamous Cell Carcinoma of Head and Neck 09/2018
1	Osteoarthritis 04/2018
1	Atrophy 02/2018
1	Fibrosis (Cirrhosis) 02/2018
1	Pain (Aches) 12/2017
1	Acne Vulgaris 10/2017
1	Fibromyalgia (Fibrositis) 05/2017
1	Chronic Pain 05/2017
1	Neoplastic Cell Transformation 02/2016
1	Oral Lichen Planus 02/2016
1	Osteoporosis 01/2016
1	Autoimmune Thyroiditis (Lymphomatous Thyroiditis) 09/2015
1	Triple Negative Breast Neoplasms 04/2015
1	Breast Neoplasms (Breast Cancer) 04/2015
1	Carcinogenesis 04/2015
1	Gout 02/2015
1	Brain Edema (Cerebral Edema) 01/2015

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2019 - 08/2008
3	AntibodiesIBA 05/2019 - 09/2015
3	Pharmaceutical PreparationsIBA 12/2017 - 03/2013
3	Cisplatin (Platino)FDA LinkGeneric 10/2004 - 11/2003
2	Histones (Histone)IBA 09/2018 - 12/2017
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018 - 07/2013
2	ametantrone (HAQ)IBA 12/2017 - 12/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015 - 09/2014
2	Etoposide (VP 16)FDA LinkGeneric 12/2003 - 11/2003
1	ORALIT (ORS)IBA 04/2022
1	PlatinumIBA 04/2022
1	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 02/2022
1	human ERBB2 proteinIBA 01/2022
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2022
1	Estrogen ReceptorsIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 10/2021
1	Opioid Analgesics (Opioids)IBA 10/2021
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 09/2021
1	CreatinineIBA 05/2019
1	CosmeceuticalsIBA 01/2019
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2019
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2019
1	2'-fucosyllactoseIBA 01/2019
1	Particulate MatterIBA 01/2019
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2019
1	theasinensin AIBA 09/2018
1	trichostatin A (A 300)IBA 09/2018
1	Anticardiolipin AntibodiesIBA 07/2018
1	C-Reactive ProteinIBA 04/2018
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 02/2018
1	Immunosuppressive Agents (Immunosuppressants)IBA 02/2018
1	metal transporting protein 1 (ferroportin)IBA 01/2018
1	Ferritins (Ferritin)IBA 01/2018
1	HepcidinsIBA 01/2018
1	IronIBA 01/2018
1	DiterpenesIBA 12/2017
1	oridoninIBA 12/2017
1	Angiogenesis InhibitorsIBA 12/2017
1	Biological ProductsIBA 12/2017
1	PolyphenolsIBA 10/2017
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 05/2017
1	Sorafenib (BAY 43-9006)FDA Link 02/2016
1	mithramycin AIBA 02/2016
1	AgarIBA 02/2016
1	Indicators and Reagents (Reagents)IBA 02/2016
1	Trypan Blue FDA Link 02/2016
1	Diphosphonates (Bisphosphonates)IBA 01/2016
1	GlucocorticoidsIBA 01/2016
1	ErbB Receptors (EGF Receptor)IBA 04/2015
1	PhosphoproteinsIBA 04/2015
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 04/2015
1	Allopurinol (Remid)FDA LinkGeneric 02/2015
1	Adalimumab (Humira)FDA Link 01/2015
1	CytokinesIBA 01/2015

Therapy/Procedure

6	Therapeutics 01/2019 - 11/2003
2	Neoadjuvant Therapy 11/2022 - 01/2022
2	Drug Therapy (Chemotherapy) 04/2022 - 10/2004
2	Hematopoietic Stem Cell Transplantation 02/2004 - 02/2004
1	Cystectomy 11/2022
1	Adjuvant Chemotherapy 11/2022
1	Long-Term Care 10/2019